TNIP3
TNFAIP3-interacting protein 3
Also known as: ABIN-3, FLJ21162, LIND, TNIP3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96KP6
- Gene
- TNIP3
- Ensembl
- ENSG00000050730
- Chromosome
- 4
- Canonical length
- 325 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol
OverviewNCBI Gene
Enables polyubiquitin modification-dependent protein binding activity. Involved in cellular response to lipopolysaccharide; negative regulation of canonical NF-kappaB signal transduction; and pattern recognition receptor signaling pathway. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
325 residues, UniProt reviewed canonical sequence.
>Q96KP6|TNIP3
1 MAHFVQGTSR MIAAESSTEH KECAEPSTRK NLMNSLEQKI RCLEKQRKEL LEVNQQWDQQ
61 FRSMKELYER KVAELKTKLD AAERFLSTRE KDPHQRQRKD DRQREDDRQR DLTRDRLQRE
121 EKEKERLNEE LHELKEENKL LKGKNTLANK EKEHYECEIK RLNKALQDAL NIKCSFSEDC
181 LRKSRVEFCH EEMRTEMEVL KQQVQIYEED FKKERSDRER LNQEKEELQQ INETSQSQLN
241 RLNSQIKACQ MEKEKLEKQL KQMYCPPCNC GLVFHLQDPW VPTGPGAVQK QREHPPDYQW
301 YALDQLPPDV QHKANGLSSV KKVHPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNIP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 6 nTPM
Expression across tissuesHPA
Tissue
- appendix: 6 nTPM
- urinary bladder: 3.9 nTPM
- tonsil: 3 nTPM
- lymph node: 2.4 nTPM
- thymus: 1.7 nTPM
- lung: 1.6 nTPM
Single-cell type
- monocytes: 200 nCPM
- t-cells: 106 nCPM
- late spermatids: 92 nCPM
- endometrial secretory cells: 46 nCPM
- early spermatids: 24 nCPM
- macrophages: 24 nCPM
Immune cell
- memory CD8 T-cell: 6.2 nTPM
- naive CD8 T-cell: 2.7 nTPM
- gdT-cell: 2.5 nTPM
- MAIT T-cell: 1.8 nTPM
- memory CD4 T-cell: 1.1 nTPM
- T-reg: 0.7 nTPM
Brain region
- pons: 6.4 nTPM
- medulla oblongata: 4.8 nTPM
- cerebral cortex: 3.7 nTPM
- white matter: 3.6 nTPM
- basal ganglia: 3.1 nTPM
- hypothalamus: 2.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.55
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- inflammatory response
- negative regulation of canonical NF-kappaB signal transduction
- regulation of transcription by RNA polymerase II
- toll-like receptor 4 signaling pathway
- MyD88-independent toll-like receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNIP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNIP3 as an antibody target. Whether an autoantibody or antibody against TNIP3 could matter depends on whether native TNIP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNIP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNIP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...